Ozempic

Ozempic is the brand of once-weekly injectable semaglutide approved for type 2 diabetes. Its label lists three jobs: improving blood sugar control alongside diet and exercise, reducing the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes and established heart disease, and slowing kidney decline in adults with type 2 diabetes and chronic kidney disease. Weight loss is not on that list, which is the single most important thing to understand about it.

That kidney indication traces to FLOW, a trial of 3,533 people with type 2 diabetes and chronic kidney disease. Over a median 3.4 years, the risk of a major kidney event — dialysis, transplant, a 50% drop in filtration rate, or death from kidney or heart causes — was 24% lower on semaglutide 1 mg weekly than on placebo. The earlier SUSTAIN-6 trial found fewer cardiovascular events, though it also flagged more retinopathy complications, which is why eye history comes up in these conversations.

Dosing starts at 0.25 mg once weekly for four weeks, moves to 0.5 mg, and can rise to 1 mg and then 2 mg, each step after at least four weeks. If a dose is missed, the label allows taking it within five days; past that, skip it and resume the normal day. Our missed-dose guide keeps the rules for each brand straight, and the pen click chart covers the mechanics.

The confusion worth clearing up: Ozempic and Wegovy are the same molecule at different ceilings, and prescribing Ozempic purely for weight loss is off-label. That is legal and common, but it changes how insurers respond, and it is why coverage denials on Ozempic-for-weight are routine. Note also that Novo now markets an oral semaglutide tablet under the Ozempic name, and the label states plainly that the tablets and the injection are not substitutable milligram for milligram.

Ask your prescriber which diagnosis is on the claim, whether your A1C or kidney numbers support the diabetes indication, and what happens if your plan requires a switch. The Ozempic drug page and our off-label prescribing explainer go deeper.